{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "PTAB Denies Sandoz’s IPR Petition for Humira®-Related Patent",
    "url": "https://www.lexblog.com/2018/05/17/ptab-denies-sandozs-ipr-petition-for-humira-related-patent/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RTWEBKWD",
        "url": "https://www.lexblog.com/lib/RTWEBKWD/"
    },
    "datePublished": "2018-05-17T13:52:14-04:00",
    "dateModified": "2021-11-09T07:50:42-05:00",
    "author": {
        "@type": "Person",
        "name": "Caitlin M. Wilmot"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Intellectual Property",
    "sourceUrl": "http://www.biosimilarsip.com/?p=4483",
    "sourceStability": "may-move"
}